Stay updated on SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial
Sign up to get notified when there's something new on the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page.

Latest updates to the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page
- Check4 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check25 days agoChange DetectedThe study history now includes additional version entries around late September 2026 and a Study Status update, while an older 2026-08-31 entry appears removed, reflecting updated record history for the trial.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page’s Revision tag has been updated to v3.7.0, replacing v3.6.6. This reflects a software version update for the page without altering its content.SummaryDifference0.0%

- Check53 days agoChange DetectedA new revision entry (v3.6.6) was added to the study record history on 2026-08-31, including a Study Status element, while the earlier revision entry (v3.6.5) from 2026-08-03 was removed.SummaryDifference0.2%

- Check75 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page, indicating a software version upgrade. The update does not alter the page content or structure.SummaryDifference0.0%

Stay in the know with updates to SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPARTAN: Apalutamide in Non-Metastatic CRPC Clinical Trial page.